trending Market Intelligence /marketintelligence/en/news-insights/trending/6j6le0e1on-fnp79wjrlla2 content esgSubNav
In This List

Cerus adds board member

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Cerus adds board member

Cerus Corp. appointed Eric Bjerkholt as a director.

Bjerkholt is the CFO of Aimmune Therapeutics Inc., which develops treatments for people with food allergies. He is also a board member at Corium International Inc.

Concord, Calif.-based Cerus develops biomedical products, with a focus on blood transfusion safety.